WILMINGTON, N.C., April 30 /PRNewswire-FirstCall/ -- Inclinix, Inc. has announced today that it has entered into a strategic partnership with DATATRAK International, Inc. (Nasdaq: DATA) to offer the most comprehensive enrollment services available to pharmaceutical, biotechnology and medical device companies globally.
This partnership will enable Inclinix to leverage DATATRAK's eClinical(TM) platform to enhance its services as a premiere enrollment Contract Research Organization (CRO). This alliance offers the first ever enrollment solution that delivers seamless integration and execution of services, reducing a Sponsor's need to outsource to multiple vendors for successful trial completion. Access to data is powerful for efficient and dynamic enrollment execution; therefore, this partnership immediately benefits both Inclinix and DATATRAK clients.
"Inclinix will be the enrollment CRO offering DATATRAK's eClinical(TM) solutions. With EDC services repeatedly becoming a request of our customers, this partnership has been in our corporate vision for quite some time. We are ecstatic that DATATRAK has entered into this strategic partnership with Inclinix," says J. Tobin Geatz, President and CEO, Inclinix. "DATATRAK's focus on ease of use and integration is a great fit into the enrollment solutions already provided by Inclinix. As a forward-looking CRO, we are continuously developing our services to improve clinical development timelines. This partnership will undoubtedly provide immediate data-driven, results-oriented solutions for our clients."
"Inclinix brings a unique skill set to our CRO Connect Program. As a CRO specializing in enrollment solutions, Inclinix's technologies and services complement DATATRAK's already comprehensive eClinical platform," said DATATRAK's CEO Laurence P. Birch. "We are pleased
|SOURCE DATATRAK International, Inc.|
Copyright©2009 PR Newswire.
All rights reserved